HomeTLX • ASX
add
Telix Pharmaceuticals Ltd
Previous close
$11.23
Day range
$10.81 - $11.39
Year range
$8.26 - $29.72
Market cap
3.83B AUD
Avg Volume
3.20M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 175.00M | — |
Operating expense | 86.85M | — |
Net income | 17.97M | — |
Net profit margin | 10.27 | — |
Earnings per share | — | — |
EBITDA | 29.78M | — |
Effective tax rate | 29.62% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.71M | — |
Total assets | 429.99M | — |
Total liabilities | 248.82M | — |
Total equity | 181.17M | — |
Shares outstanding | 324.06M | — |
Price to book | 20.05 | — |
Return on assets | 17.21% | — |
Return on capital | 38.88% | — |
Cash Flow
Net change in cash
| (AUD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 17.97M | — |
Cash from operations | 5.47M | — |
Cash from investing | -8.91M | — |
Cash from financing | -1.46M | — |
Net change in cash | -529.00K | — |
Free cash flow | -16.37M | — |
About
Founded
2015
Website
Employees
1,152
